Position in HIMS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$96,937
+$47,113 QoQ
Shares Held
2,796
+16.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#369
of 504 holders
Holding Since
Mar 2022
7 quarters on record
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Geneos Wealth Management Inc. holds $7,070,693 across 8 Drug Manufacturers - Specialty & Generic names. HIMS ranks #5 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
207,575 | $5,108,420 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
31,507 | $1,067,457 | |
| 3 | DERM |
Journey Medical Corp
|
63,280 | $448,022 | |
| 4 | ZTS |
Zoetis Inc.
|
3,895 | $279,894 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
This page
|
2,796 | $96,937 | |
| 6 | VTRS |
Viatris Inc
|
3,677 | $58,390 | |
| 7 | HLN |
Haleon plc
|
713 | $6,652 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
307 | $4,921 |
All Filings in HIMS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $96,937 | 2,796 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $49,824 | 2,400 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $71,434 | 2,200 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $125,918 | 2,220 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $51,345 | 1,030 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $30,081 | 1,018 | Shares | Sole | 2025-05-08 | |
| 2022-03-31 | $11,459 | 2,150 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||